Literature DB >> 10873962

Effect of interleukin 17 on proteoglycan degradation in murine knee joints.

J Dudler1, N Renggli-Zulliger, N Busso, M Lotz, A So.   

Abstract

OBJECTIVE: To evaluate the effect of murine interleukin 17 (IL17) on cartilage catabolism and joint inflammation by direct intra-articular injection of the cytokine into murine knee joints.
METHODS: Knees of normal C57 Bl mice were injected once or repeatedly with recombinant IL17 or IL1beta. Inflammation was estimated by technetium-99m pertechnetate ((99)Tc) uptake and histological scoring of tissue sections. Proteoglycan depletion was evaluated by histological scoring of safranin O stained sections. Effects on proteoglycan synthesis were studied by (35)SO(4) incorporation.
RESULTS: A single intra-articular injection of IL17 (10 ng/knee) produced effects very similar to those of IL1beta (10 ng/knee). No inflammation was detected at six or 24 hours by (99)Tc uptake. However, safranin O staining showed depletion of proteoglycan at 48 hours. Repeated injections of IL17 induced joint inflammation and cartilage proteoglycan depletion as shown by histological scoring. Unlike IL1beta, proteoglycan depletion induced by IL17 seemed to be the result of increased degradation only, as no suppression of (35)SO(4) incorporation was seen.
CONCLUSION: These findings confirm, in vivo, the catabolic effects of IL17 on cartilage. IL17 is thus the first T cell cytokine showing a direct catabolic effect on cartilage in addition to stimulatory effects on macrophages and synoviocytes, making it a potentially important cytokine in the pathogenesis of arthritis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873962      PMCID: PMC1753181          DOI: 10.1136/ard.59.7.529

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  22 in total

1.  Direct effect of murine rIL-1 on cartilage metabolism in vivo.

Authors:  A A van de Loo; H M van Beuningen; P L van Lent; W B van den Berg
Journal:  Agents Actions       Date:  1989-01

2.  Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor.

Authors:  Z Yao; W C Fanslow; M F Seldin; A M Rousseau; S L Painter; M R Comeau; J I Cohen; M K Spriggs
Journal:  Immunity       Date:  1995-12       Impact factor: 31.745

3.  Interleukin-17: A new bone acting cytokine in vitro.

Authors:  R L Van bezooijen; H C Farih-Sips; S E Papapoulos; C W Löwik
Journal:  J Bone Miner Res       Date:  1999-09       Impact factor: 6.741

4.  In vivo effects of interleukin-1 on articular cartilage. Prolongation of proteoglycan metabolic disturbances in old mice.

Authors:  H M van Beuningen; O J Arntz; W B van den Berg
Journal:  Arthritis Rheum       Date:  1991-05

5.  Effects of murine recombinant interleukin 1 on intact homologous articular cartilage: a quantitative and autoradiographic study.

Authors:  W B van den Berg; F A van de Loo; W A Zwarts; I G Otterness
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

6.  Quantitation of arthritis by 99mTc-uptake measurements in the mouse knee-joint: correlation with histological joint inflammation scores.

Authors:  J W Lens; W B van den Berg; L B van de Putte
Journal:  Agents Actions       Date:  1984-06

7.  CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene.

Authors:  E Rouvier; M F Luciani; M G Mattéi; F Denizot; P Golstein
Journal:  J Immunol       Date:  1993-06-15       Impact factor: 5.422

8.  Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation.

Authors:  A A van de Loo; W B van den Berg
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

9.  Human IL-17: a novel cytokine derived from T cells.

Authors:  Z Yao; S L Painter; W C Fanslow; D Ulrich; B M Macduff; M K Spriggs; R J Armitage
Journal:  J Immunol       Date:  1995-12-15       Impact factor: 5.422

10.  T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.

Authors:  F Fossiez; O Djossou; P Chomarat; L Flores-Romo; S Ait-Yahia; C Maat; J J Pin; P Garrone; E Garcia; S Saeland; D Blanchard; C Gaillard; B Das Mahapatra; E Rouvier; P Golstein; J Banchereau; S Lebecque
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

View more
  21 in total

Review 1.  IL-17 and limits of success.

Authors:  Zahra Omidian; Rizwan Ahmed; Adebola Giwa; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cell Immunol       Date:  2018-09-17       Impact factor: 4.868

Review 2.  Interleukin-17 and its expanding biological functions.

Authors:  Sheng Xu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2010-04-12       Impact factor: 11.530

Review 3.  Lessons from animal models of arthritis.

Authors:  Wim B Van den Berg
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

4.  Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis.

Authors:  A Kehlen; K Thiele; D Riemann; J Langner
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

5.  Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro.

Authors:  R L Van Bezooijen; L Van Der Wee-Pals; S E Papapoulos; C W G M Löwik
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

6.  Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines.

Authors:  P J Koshy; N Henderson; C Logan; P F Life; T E Cawston; A D Rowan
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

7.  SKLB023 blocks joint inflammation and cartilage destruction in arthritis models via suppression of nuclear factor-kappa B activation in macrophage.

Authors:  Caifeng Xie; Liang Ma; Juan Liu; Xiuxia Li; Heying Pei; Mingli Xiang; Lijuan Chen
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

8.  Gain of CXCR7 function with mesenchymal stem cell therapy ameliorates experimental arthritis via enhancing tissue regeneration and immunomodulation.

Authors:  Sung-Tai Wei; Yen-Chih Huang; Jung-Ying Chiang; Chia-Ching Lin; Yu-Jung Lin; Woei-Cherng Shyu; Hui-Chen Chen; Chia-Hung Hsieh
Journal:  Stem Cell Res Ther       Date:  2021-05-29       Impact factor: 6.832

9.  Active immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis.

Authors:  Laure Delavallée; Luca Semerano; Eric Assier; Géraldine Vogel; Grégoire Vuagniaux; Marion Laborie; Daniel Zagury; Natacha Bessis; Marie-Christophe Boissier
Journal:  Arthritis Res Ther       Date:  2009-12-23       Impact factor: 5.156

10.  Gene expression induced by interleukin-17 in fibroblast-like synoviocytes of patients with rheumatoid arthritis: upregulation of hyaluronan-binding protein TSG-6.

Authors:  A Kehlen; A Pachnio; K Thiele; J Langner
Journal:  Arthritis Res Ther       Date:  2003-04-28       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.